Targeted Medical Pharma Inc TRGM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.01 / $0.02
- Market Cap
- $3,018.57
- Volume/Avg
- 11,681 / 8,341
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Targeted Medical Pharma Inc is a United States based specialty pharmaceutical company, which develops and commercializes amino acid-based medications. The business activities of the group are functioned through Targeted Medical Pharma; Complete Claims Processing, Inc. and Amino Nutritionals segments. The operations of the group are primarily functioned through the region of United States and it derives the majority of revenue from Targeted Medical Pharma segment which develops and distributes amino acid-based therapeutic products and distributes pharmaceutical products from other manufacturers through employed sales representatives, independent distributors, and pharmacies.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 30
- Website
- http://www.tmedpharma.com
Valuation
|
Metric
|
TRGM
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
TRGM
|
|---|---|
Quick Ratio | 0.04 |
Current Ratio | 0.06 |
Interest Coverage | −1.61 |
Quick Ratio
TRGM
Profitability
|
Metric
|
TRGM
|
|---|---|
Return on Assets (Normalized) | −112.57% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
TRGM
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Fqsvxzhhc | Cvjgqmh | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Yhhjdlkqph | Nbwj | $68.9 Bil | |
HLN
| Haleon PLC ADR | Bdcdpbxr | Hbyb | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Wgkbtmzc | Tvrm | $14.7 Bil | |
VTRS
| Viatris Inc | Dxjpqxgb | Xwq | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Ftnvrfhy | Xxmgq | $11.9 Bil | |
CTLT
| Catalent Inc | Thkkzyssc | Jsmdpk | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Qktvvsqn | Zfdyq | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Jmtpdmgf | Yfdhr | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Cxjpsqjq | Qxpnxbb | $3.5 Bil |